Are patients with Chronic Obstructive Pulmonary Disease treated according to guidelines with non-invasive ventilation when 30-day mortality rates rise? Results of an internal audit.
Main Article Content
Abstract
Introduction: Chronic Obstructive Pulmonary Disease (COPD) in exacerbation is globally a frequent cause of admission. In Denmark, annual national epidemiological data on COPD patients have been reported since 2008, and there has been registered a reduction in admissions due to COPD in exacerbation of approximately 25% compared to 2014. There has also been revealed regional differences in use of non-invasive ventilation (NIV) and mortality, and especially, the 30-day mortality rate was significantly higher at Odense University Hospital compared to the other regions in 2022, where the number of admissions was even lower due to the effect of the COVID-19 pandemic. We therefore decided to repeat an internal audit of all admissions with COPD exacerbation with focus on in-house initiation of NIV as an add-on treatment to standard treatment and mortality.
Methods: Patient data was collected from medical records from the COPD cohort, and the cohort was defined by discharge between 1st of January to 31st of December 2023, admission at Odense University Hospital, and confirmed COPD exacerbation.
Results: The COPD cohort comprised in all 396 patients. NIV criteria were fulfilled in 112 patients and initiation of NIV in 92.9%. The 30-day mortality rate was in this cohort 16.2%. Patients who died within 30 days, were significantly older than patients still alive, although there was no difference in comorbidities. The patients, who received NIV and died, had significantly fewer comorbidites compared to patients who died and did not receive NIV.
Conclusions: Acute treatment was given according to guidelines, and the need of NIV was found in 28% of the patients in the cohort. The patients that died were significantly older compared to survivors. The increased mortality can therefore be a consequence of admissions with an ageing population, and, hence, more fragile COPD patients.
The COPD population in Denmark is getting older, although there are still some patients with severe COPD dying at younger age.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Løkke A, Hilberg O, Tønnesen P, Ibsen R, Kjellberg J, Jennum P. Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010. BMJ open. 2014;4(1).
3. Bilde L, Svenning AR, Dollerup J, Borgeskov HB, Lange P. The cost of treating patients with COPD in Denmark - a population study of COPD patients compared with non-COPD controls. Respir Med. 2007;Mar:101(3):539-49.
4. Lange P, Tøttenborg SS, Sorknæs AD et al. Danish Register of chronic obstructive pulmonary disease. Clinical Epidemiology 2016;8 673-678
5. RKKPs Videncenter med fagligsparring fra formandsskabet i DrKOL. Dansk register for Kronisk Obstruktiv Lungesygdom – DrKOL. Årsrapport for 2022 – 1. Januar til 31. December 2022. Available from: Dansk register for Kronisk Obstruktiv Lungesygdom (DrKOL) - RKKP (19-08-2024)
6. Sundhedsstyrelsen. KOL – anbefalinger for tidlig opsporing, opfølgning, behandling og rehabilitering. Copenhagen: Sundhedsstyrelsen, 2006. Electronic ISBN: 87-7676-393-5
7. Regional COPD health plan. Available from: Tværsektorielt forløbsprogram for KOL-patienter (regionsyddanmark.dk) (21-07-2024)
8. Danish Telemedicine: Available from: TeleKOL - Telemedicinsk tilbud - sundhed.dk (21-07-2024)
9. Titlestad IL, Bryde J, Øberg-Hansen B, Lassen AT, Vestbo J. Reorganisation of acute referral to an emergency department resulted in fewer admissions for chronic obstructive pulmonary disease but in higher rates of non-invasive ventilation. Dan Med J 2014;61(11):A4958.
10. Emergency Department organization. Available from Emergency Department, OUH (21-07-2024)
11. Roberts CM, Stone RA, Buckingham RJ, Pursey NA, Lowe D. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax 2011;66:43-48.
12. Tøttenborg SS, Johnsen SP, Thomsen RW, Nielsen H, Hansen EF, Lange P. Use of non-invasive ventilation is increasing in patients admitted with a chronic obstructive pulmonary disease exacerbation. Dan Med J 2013;60(8):A4686
13. Hurst JR, Quint JK, Stone RA, Silove Y, Youde J, Roberts CM. National clinical audit for hospitalised exacerbations of COPD. ERJ Open Res. 2020;Sep 21;6(3):00208-2020. doi: 10.1183/23120541.00208-2020. PMID: 32984418; PMCID: PMC7502696.
14. Titlestad IL, Madsen HD. Implementation of non-invasive ventilation in respiratory ward in patients with exacerbations of chronic obstructive pulmonary disease. Ugeskr Laeger. 2008;170(4):240-3.
15. Jayadev A, Stone R, Steiner MC, McMillan V, Roberts CM. BMJ Open Resp Res 2019;6:e000444. doi:10.1136/bmjresp-2019-000444
16. Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22. PMID: 26493806.